Alvotech and Dr. Reddy’s will collaborate to co-develop a biosimilar candidate to Keytruda (pembrolizumab) for global markets, it said in an exchange filing.
Alvotech and Dr. Reddy’s will collaborate to co-develop a biosimilar candidate to Keytruda (pembrolizumab) for global markets, it said in an exchange filing.